Medicare Enrolled
Dr. Daniel Dino, M.D.
Geriatric Medicine (Internal Medicine) Physician · St Marys, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dino
Dr. Daniel Dino is a geriatric medicine physician in St Marys, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Dino performed 4,382 Medicare services across 1,637 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dino received a total of $13,139 from 55 pharmaceutical and/or device companies across 805 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in geriatric medicine (internal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 7% volume in GA
$13,139 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,382
Medicare services
Top 7% in GA for geriatric medicine (internal medicine) physician
1,637
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~243 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,221 | $18 | $29 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
652 | $83 | $183 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
312 | $121 | $162 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
177 | $56 | $123 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
162 | $29 | $34 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
154 | $72 | $145 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
94 | $10 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
69 | $124 | $240 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
54 | $39 | $128 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
50 | $29 | $34 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
47 | $263 | $418 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
46 | $0 | $12 |
| Ear wax removal by washing This procedure involves the removal of impacted ear wax using a washing technique. |
45 | $12 | $74 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
43 | $29 | $89 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
33 | $2 | $28 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
33 | $16 | $59 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
26 | $37 | $50 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
26 | $124 | $262 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
21 | $61 | $142 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
19 | $207 | $682 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $109 | $263 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
15 | $35 | $113 |
| Respiratory syncytial virus (RSV) immunoassay test A laboratory test that uses an immunoassay technique to detect the presence of respiratory syncytial virus in a sample. The results are determined through direct visual observation of the test reaction. |
15 | $13 | $68 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
15 | $152 | $482 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
13 | $128 | $244 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
12 | $10 | $76 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
12 | $16 | $54 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,139
Total received (2018-2024)
Avg $1,877/year across 7 years
Top 4% in GA for geriatric medicine (internal medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
805
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,139 (100.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,238
2023
$2,323
2022
$2,137
2021
$1,971
2020
$1,169
2019
$1,580
2018
$1,721
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$282
AstraZeneca Pharmaceuticals LP
$245
Lilly USA, LLC
$218
Amgen Inc.
$187
GlaxoSmithKline, LLC.
$166
Otsuka America Pharmaceutical, Inc.
$141
ABBVIE INC.
$117
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$114
Phathom Pharmaceuticals, Inc.
$105
Astellas Pharma US Inc
$97
Bayer Healthcare Pharmaceuticals Inc.
$97
Exact Sciences Corporation
$82
E.R. Squibb & Sons, L.L.C.
$73
Dexcom, Inc.
$50
Insulet Corporation
$46
Novartis Pharmaceuticals Corporation
$45
Almatica Pharma LLC
$43
Abbott Laboratories
$40
PFIZER INC.
$24
UCB, Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Merck Sharp & Dohme LLC
$15
Bausch Health US, LLC
$13
Top 3 companies account for 33.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,513
Novo Nordisk Inc
$1,373
GlaxoSmithKline, LLC.
$1,204
Amgen Inc.
$818
Lilly USA, LLC
$774
AbbVie Inc.
$632
Janssen Pharmaceuticals, Inc
$606
Astellas Pharma US Inc
$585
PFIZER INC.
$528
Otsuka America Pharmaceutical, Inc.
$449
Novartis Pharmaceuticals Corporation
$426
Merck Sharp & Dohme Corporation
$345
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$344
ABBVIE INC.
$223
Insulet Corporation
$218
Amarin Pharma Inc.
$214
Takeda Pharmaceuticals U.S.A., Inc.
$201
Biohaven Pharmaceuticals, Inc.
$191
E.R. Squibb & Sons, L.L.C.
$187
Biohaven Pharmaceutical Holding Company Ltd.
$178
Ferring Pharmaceuticals Inc.
$170
Allergan, Inc.
$164
Abbott Laboratories
$161
Boehringer Ingelheim Pharmaceuticals, Inc.
$133
Dexcom, Inc.
$120
Eisai Inc.
$105
Phathom Pharmaceuticals, Inc.
$105
Exact Sciences Corporation
$102
Sunovion Pharmaceuticals Inc.
$99
Bayer Healthcare Pharmaceuticals Inc.
$97
SANOFI-AVENTIS U.S. LLC
$83
Merck Sharp & Dohme LLC
$78
SANOFI PASTEUR INC.
$74
Almatica Pharma LLC
$71
UCB, Inc.
$64
IDORSIA PHARMACEUTICALS US INC
$57
Allergan Inc.
$49
UROVANT SCIENCES INC
$47
Vertos Medical, Inc.
$47
Nevro Corp.
$41
Medtronic, Inc.
$39
ARBOR PHARMACEUTICALS, INC.
$25
Shire North American Group Inc
$22
VBI Vaccines (Delaware) Inc.
$22
Boston Scientific Corporation
$19
Teva Pharmaceuticals USA, Inc.
$18
Xeris Pharmaceuticals, Inc.
$18
Nestle HealthCare Nutrition Inc.
$17
Pacira Pharmaceuticals Incorporated
$16
Medtronic Vascular, Inc.
$15
Bausch Health US, LLC
$13
DEXCOM, INC.
$13
Gilead Sciences, Inc.
$13
Hikma Pharmaceuticals USA
$13
Sumitomo Pharma America, Inc.
$1
Top 3 companies account for 31.1% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · BELSOMRA · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Bimzelx · CAMZYOS · CHANTIX · COMIRNATY · Cimzia · Cologuard Collection Kit · DALIRESP · DEXCOM G6 TRANSMITTER · Dayvigo · Descovy · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUFLEXXA · EVENITY · Edarbi · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GATTEX · GEMTESA · GENERAL PAIN MANAGEMENT · GRALISE · GVOKE PFS · INTELLIS ADAPTIVESTIM · INVOKANA · JANUMET · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NAPRELAN · NURTEC ODT · Omnia · Omnipod · Otezla · Ozempic · PNEUMOVAX 23 · PRADAXA · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PreHevbrio · Prolia · QULIPTA · QUVIVIQ · REXULTI · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Senza Spinal Cord Stimulation System · TEFLARO · TERIPARATIDE · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Trintellix · UBRELVY · VESICARE · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · VenaSeal · Veozah · Victoza · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for geriatric medicine (internal medicine) physician in GA.
Geographic Context
Geriatric medicine physicians within 10 mi
2
Per 100K population
3.6
County median income
$72,399
Nearest hospital
SOUTHEAST GEORGIA HEALTH SYSTEM -- CAMDEN CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dino is a clinical cardiology specialist, with above-average Medicare volume (top 7% in GA), with low-engagement industry engagement in the top 4% of GA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dino experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Dino performed 2,221 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dino receive payments from pharmaceutical companies?
Yes. Dr. Dino received a total of $13,139 from 55 companies across 805 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dino's costs compare to other geriatric medicine physicians in St Marys?
Dr. Dino's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Geriatric Medicine Physicians in St Marys
Browse geriatric medicine physicians in St Marys ranked by procedure volume and transparency data.
Highest volume
Top Geriatric Medicine Physicians in GA
Geriatric medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Geriatric Medicine Physicians in GA
Which GA geriatric medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology